Germany’s coalition government has retreated further on its controversial medical cannabis reimbursement reforms as it faces mounting questions over how and why the law came to be. A swathe of ...
Thousands of Dutch patients are facing a 10-month supply gap for medically essential Bedrocan products, including varieties clinicians consider irreplaceable for children with treatment-resistant ...
James Duckenfield, CEO of Glass Pharms ®, dives into the responsibilities behind a medical cannabis brand and why pharmaceutical standards should matter more than marketing. From cultivation controls ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results